Apyx Medical (APYX) Change in Accured Expenses (2011 - 2026)
Apyx Medical (APYX) posted Change in Accured Expenses of -$1.8 million for Q1 2026, down 418.08% on a QoQ basis from $553000.0 in Q4 2025, and down 105.49% year-over-year from $32.0 million in Q1 2025.
Apyx Medical (APYX) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Apyx Medical's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 105.49% year-over-year to -$1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$694000.0 (up 55.23% YoY) and the FY2025 annual result came in at $209000.0, up 109.22% from the prior year.
- Change in Accured Expenses was -$1.8 million for Q1 2026 at Apyx Medical, down from $553000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.8 million in Q3 2022 and bottomed at -$2.0 million in Q2 2023.
- A 5-year average of -$236066.7 and a median of $67000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses slumped 2447.76% — and 2025, when it surged 546.39%.
- Apyx Medical's Change in Accured Expenses stood at $1.8 million in 2022, then decreased by 21.09% to $1.4 million in 2023, then sank by 93.84% to $88000.0 in 2024, then soared by 528.41% to $553000.0 in 2025, then sank by 418.08% to -$1.8 million in 2026.
- Business Quant data shows APYX's Change in Accured Expenses at -$1.8 million in Q1 2026, $553000.0 in Q4 2025, and $79000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Apyx Medical | 167.53 Mn | 136.65 Mn | 7.93 Mn | -1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.76 Mn |
| Mar 31, 2026 | -1.76 Mn |
| Dec 31, 2025 | 553,000.00 |
| Dec 31, 2025 | 553,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | -856,000.00 |
| Mar 31, 2025 | -856,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Jun 30, 2024 | -97,000.00 |
| Jun 30, 2024 | -97,000.00 |
| Mar 31, 2024 | -1.57 Mn |
| Mar 31, 2024 | -1.57 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Dec 31, 2023 | 1.43 Mn |